Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer

Meletios A Dimopoulos; G. Louras; D Pantazopoulos; C. Deliveliotis; C. Constantinidis; C. Papadimitriou; Constantinos Papadimitris; Zacharias Kyriakakis; Dionysios Mitropoulos; V. Georgoulias

doi:10.1016/s0959-8049(97)84533-9

Related publications

Article1997

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Zacharias Kyriakakis, Meletios A Dimopoulos, A. Kostakopoulos, Aristidis Karayiannis, F. Sofras, Anastasios Zervas, Aristidis Giannopoulos, C Dimopoulos

Article1997

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Zacharias Kyriakakis, Meletios A Dimopoulos, A. Kostakopoulos, Aristidis Karayiannis, F. Sofras, Anastasios Zervas, Aristidis Giannopoulos, C Dimopoulos

Article1999

Paclitaxel, cisplatin and epirubicin (PCE) combination chemotherapy for newly diagnosed patients with advanced epithelial ovarian cancer (AEOC)

Christos Papadimitriou, Αchilles Anagnostopoulos, Zannis Voulgaris, George Vlahos, E. Kioses, T. Akrivos, Meletios A Dimopoulos

Article2001

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

D. Pectasides, Gerasimos Aravantinos, Haralabos P. Kalofonos, Christos Kiamouris, D. Bafaloukos, Nikolaos I. Xiros, C. Nicolaides, A. Visvikis, Meletios A Dimopoulos

Article2000

Cisplatin, epirubicin and paclitaxel combination chemotherapy in previously untreated patients with advanced epithelial ovarian cancer

Christos Papadimitriou, D. Lazaris, Alexandros Rodolakis, Christos Kiamouris, Georgios M. Gourgoulis, Eleni Galani, E Diakomanolis, S. Michalas, Meletios A Dimopoulos

Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer

Discussion(0)

Related publications

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Paclitaxel, cisplatin and epirubicin (PCE) combination chemotherapy for newly diagnosed patients with advanced epithelial ovarian cancer (AEOC)

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

Cisplatin, epirubicin and paclitaxel combination chemotherapy in previously untreated patients with advanced epithelial ovarian cancer